CD8A and renal cell carcinoma: The applicability of these findings to other tumors was demonstrated in an RCC cohort, in which B lineage scores was predictive of response (p=2.6e-03), and differential effects were again seen between CD8 T-cell low (p=0.008) and high cases (p=0.564).